Richard E Lowenthal's Net Worth
$49.4 Million
Who is Richard E Lowenthal?
Richard E Lowenthal has an estimated net worth of $49.4 Million. This is based on reported shares across multiple companies, which include ARS Pharmaceuticals, Inc., and CADENCE PHARMACEUTICALS INC.
SEC CIK
Richard E Lowenthal's CIK is 0001378550
Past Insider Trading and Trends
2022 was Richard E Lowenthal's most active year for acquiring shares with 3 total transactions. Richard E Lowenthal's most active month to acquire stocks was the month of October. 2024 was Richard E Lowenthal's most active year for disposing of shares, totalling 2 transactions. Richard E Lowenthal's most active month to dispose stocks was the month of March. 2024 saw Richard E Lowenthal paying a total of $199,998.84 for 1,068,491 shares, this is the most they've acquired in one year. In 2023 Richard E Lowenthal cashed out on 1,050,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ARS Pharmaceuticals, Inc. (SPRY) Snapshot price: $11.5
PRESIDENT AND CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.40% | -100.00K |
$11.50 | -$1,149,775.00 | 2.84M |
Scheduled
|
Sep 10
| ||
Form 4
| -3.23% | -100.00K |
$12.48 | -$1,247,554.99 | 2.99M |
Scheduled
|
Aug 13
| ||
Form 4
| -3.08% | -100.00K |
$11.40 | -$1,140,295.00 | 3.15M |
Scheduled
|
Jul 16
| ||
Form 4
| -3.08% | -100.00K |
$9.62 | -$961,725.00 | 3.14M |
Scheduled
|
Jul 9
| ||
Form 4
| -2.99% | -100.00K |
$9.14 | -$913,916.74 | 3.24M |
Scheduled
|
Jun 11 - Jun 12
| ||
Form 4
| -1.49% | -100.00K |
$9.04 | -$905,441.30 | 6.63M |
Scheduled
|
May 14 - May 16
| ||
Form 4
| -2.86% | -100.00K |
$9.34 | -$934,365.00 | 3.39M |
Scheduled
|
May 7
| ||
Form 4
| +4.00% | 130.99K |
$1.06 | $138,990.12 | 3.41M |
Apr 23
| |||
Form 4
| +4.57% | 188.49K |
$1.06 | $199,998.84 | 4.32M |
Apr 19
| |||
Form 4
| -2.78% | -100.00K |
$9.28 | -$928,005.00 | 3.5M |
Scheduled
|
Apr 16
| ||
Form 4
| -2.74% | -100.00K |
$9.28 | -$927,735.00 | 3.54M |
Scheduled
|
Apr 9
| ||
Form 4
| -2.61% | -97.61K |
$9.12 | -$890,322.34 | 3.65M |
Scheduled
|
Mar 22 - Mar 25
| ||
Form 4
| -0.06% | -2.39K |
$9.02 | -$21,572.06 | 3.74M |
Scheduled
|
Mar 19 - Mar 21
| ||
Form 4
| -2.64% | -100.00K |
$9.14 | -$913,681.28 | 3.69M |
Scheduled
|
Mar 13 - Mar 15
| ||
Form 4
| -0.07% | -3.78K |
$9.02 | -$34,100.58 | 5.54M |
Scheduled
|
Feb 29
| ||
Form 4
| -1.76% | -99.48K |
$9.02 | -$897,368.26 | 5.55M |
Scheduled
|
Feb 26 - Feb 28
| ||
Form 4
|
—
|
0
|
—
|
—
| 9.5M |
May 17 - Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
∞
| 13.05M |
—
|
—
| 13.05M |
Nov 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CADENCE PHARMACEUTICALS INC No price found
VP
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||